COMBINATION BCL-2 INHIBITOR THERAPY WITH VENETOCLAX AND NAVITOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA
Pullarkat, V. A., Stock, W., Lacayo, N. J., Jabbour, E., Bajel, A., Rubnitz, J., Leonard, J., Mullighan, C. G., Khaw, S. L., Vear, S. I., Salem, A., Schmidt, M., Tong, B., Zhou, Y., Ross, J. A., BensmVolume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000562032.16534.05
Date:
June, 2019
File:
PDF, 1.06 MB
2019